EW - Edwards gets FDA okay for Evoque tricuspid valve replacement system
2024-02-02 10:51:42 ET
More on Edwards Lifesciences
- Edward Lifesciences: Still Not A Buy But Getting Closer
- Edwards Lifesciences: Undervalued With A Substantial Upside Potential
- Edwards Lifesciences provides 2024 outlook, OKs additional $1B stock buyback
- Edwards Lifesciences slips as Wolfe downgrades on emerging rivalry
- Seeking Alpha’s Quant Rating on Edwards Lifesciences